Feb. 27, 2024, 5:44 a.m. | L. Domingo, M. Chehimi, S. Banerjee, S. He Yuxun, S. Konakanchi, L. Ogunfowora, S. Roy, S. Selvaras, M. Djukic, C. Johnson

cs.LG updates on arXiv.org arxiv.org

arXiv:2309.03919v2 Announce Type: replace-cross
Abstract: The field of drug discovery hinges on the accurate prediction of binding affinity between prospective drug molecules and target proteins, especially when such proteins directly influence disease progression. However, estimating binding affinity demands significant financial and computational resources. While state-of-the-art methodologies employ classical machine learning (ML) techniques, emerging hybrid quantum machine learning (QML) models have shown promise for enhanced performance, owing to their inherent parallelism and capacity to manage exponential increases in data dimensionality. Despite …

abstract art arxiv computational cs.lg discovery disease drug discovery financial fusion hybrid influence molecules network neural network prediction predictions protein proteins quant-ph quantum resources state type

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne

Senior Machine Learning Engineer (MLOps)

@ Promaton | Remote, Europe

Senior ML Engineer

@ Carousell Group | Ho Chi Minh City, Vietnam

Data and Insight Analyst

@ Cotiviti | Remote, United States